
KeepMED
closedDeveloping disruptive solutions for the treatment of Obstructive Sleep Apnea (OSA).
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
$15.1m | Series C | ||
Total Funding | 000k |
Related Content
Keepap.com operates in the medical device industry, focusing on innovative solutions for Obstructive Sleep Apnea (OSA). The company's flagship product is a wearable, hoseless Positive Airway Pressure (PAP) device integrated into lightweight headgear, designed to provide therapeutic PAP on demand with minimal airflow. This product aims to improve the health and quality of life for individuals suffering from OSA by offering complete freedom of movement and enhanced mobility.
The primary clients are individuals diagnosed with Obstructive Sleep Apnea, a condition characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep. The market for this product includes healthcare providers, sleep clinics, and direct-to-consumer sales channels.
Keepap.com operates on a business model that includes direct sales, partnerships with healthcare providers, and potential subscription services for ongoing product updates and support. Revenue is generated through the sale of the wearable PAP devices and possibly through ancillary services such as maintenance and customer support.
The company is led by Alex Rapoport, a serial entrepreneur with extensive experience in the medical device industry, and Nir Weiss, who has a strong background in multidisciplinary product and system development. The leadership team brings a wealth of expertise in medical technology and product innovation.
Keywords: Obstructive Sleep Apnea, wearable PAP device, medical device, healthcare, mobility, therapeutic PAP, lightweight headgear, direct-to-consumer, sleep clinics, innovation.